+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis



Macrophage activation syndrome and autoimmunity due to visceral leishmaniasis



Archives de Pediatrie 22(4): 397-400



Hemophagocytic syndromes are a heterogeneous group of diseases characterized by an excessive immune response, mediated by activated cytotoxic T cells and macrophages. Among hemophagocytic syndromes, genetic and secondary forms can be distinguished. We report on the case of a male newborn who presented with macrophage activation syndrome associated with lymphoproliferation with favorable outcome under prednisone and cyclosporin. Hemopathy, infection, or genetic lymphohistiocytosis were initially ruled out. Severe autoimmunity was suspected because of positive antinuclear antibodies and Farr test associated with anemia and a positive Coombs test as well as cytolytic hepatitis with anti-liver, kidney microsome (LKM) antibodies. Treatment was therefore intensified by adding mycophenolate mofetil. This led to an unexpected deterioration of general health and lab exam results with recurrence of fever and inflammation. The initial investigations were revisited and completed by a liver biopsy, which revealed the presence of numerous leishmania parasites at the amastigote stage, enabling the diagnosis of visceral leishmaniasis. The patient's condition dramatically improved under liposomal amphotericin B treatment. Our observation shows that visceral leishmaniasis can present as lupus-like syndrome with lymphoproliferation. Moreover, the lack of leishmania on marrow aspiration cannot rule out the diagnosis of visceral leishmaniasis. Detection of leishmania by serological or molecular tests is mandatory in case of hepatosplenomegaly with hemophagocytic syndrome together with autoantibodies, in order to avoid useless and life-threatening exposure to immunosuppressive treatments.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058253700

Download citation: RISBibTeXText

PMID: 25617995

DOI: 10.1016/j.arcped.2014.11.025


Related references

Visceral leishmaniasis leading to macrophage activation syndrome. Medecine et Maladies Infectieuses 2019, 2019

Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis. La Tunisie Medicale 77(12): 648-650, 2000

Inappropriate macrophage activation syndrome associated with visceral leishmaniasis in an infant. Tunisie Medicale 77(12): 648-650, 1999

Severe macrophage activation syndrome following visceral leishmaniasis in a child. Medecine et Sante Tropicales 24(2): 221-223, 2015

Visceral Leishmaniasis Associated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage in a Lupus Patient. Acta Medica Portuguesa 31(10): 593-596, 2018

Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease. Internal Medicine Journal 46(11): 1347-1348, 2016

Visceral leishmaniasis and bronchial asthma: influence of steroid therapy in the development of the macrophage activation syndrome and relative adrenal insufficiency. Anales de Medicina Interna 25(6): 279-283, 2009

Polyclonal B cell activation, circulating immune complexess and autoimmunity in human American visceral leishmaniasis. Clinical and experimental immunology 56(1): 58-66, 1984

Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology 8: 181, 2018

Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response. Cytokine 113: 200-215, 2018

Syndrome of activation of the mononuclear phagocyte system. Initial manifestation of visceral leishmaniasis. Archives Francaises de Pediatrie 45(1): 45-46, 1988

Analysis of different macrophage population to study role of macrophage in generation of specific immune protection in visceral leishmaniasis. Indian Journal of Parasitology 14(2): 129-133, 1990

Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab. Joint, Bone, Spine 77(3): 271-273, 2010

Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations. International Journal of Dermatology 46(12): 1326, 2008

Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). International Journal of Dermatology 48(1): 59-61, 2009